Novel SN38 derivative-based liposome as anticancer prodrug: an in vitro and in vivo study

Novel SN38 derivative-based liposome as anticancer prodrug: an in vitro and in vivo study

Chan Wu,1,* Yang Zhang,1,2,* Daoqiu Yang,3,* Jinfeng Zhang,4 Juanjuan Ma,1 Dan Cheng,1 Jianming Chen,1,5 Li Deng1 1Department of Pharmaceutics, School of Pharmacy, Second Military Medical University, Shanghai 200433, People’s Republic of China; 2Department of Pharmacy, Shanghai Tenth Peopl...

Full description

Bibliographic Details
Main Authors: Wu C, Zhang Y, Yang D, Zhang J, Ma J, Cheng D, Chen J, Deng L
Format: Article
Language:English
Published: Dove Medical Press 2018-12-01
Series:International Journal of Nanomedicine
Subjects:
SN38
lipophilic prodrug
long-circulating liposome
pharmacokinetics
biodistribution
pharmacodynamics
Online Access:https://www.dovepress.com/novel-sn38-derivative-based-liposome-as-anticancer-prodrug-an-in-vitro-peer-reviewed-article-IJN

Internet

https://www.dovepress.com/novel-sn38-derivative-based-liposome-as-anticancer-prodrug-an-in-vitro-peer-reviewed-article-IJN

Similar Items